Wire Stories
-
26.6KCyara Acquires Spearline to Deliver World’s Most Comprehensive Customer Experience Assurance Platform
Strategic acquisition expands Cyara�s solutions for AI and cloud contact center migration assurance REDWOOD CITY, Calif.–(BUSINESS WIRE)–Cyara, the creator and leader of...
-
29.4KNew Global Refinery Capacity Caters to High-Demand Hotspots, an Industrial Info News Alert
SUGAR LAND, Texas–(BUSINESS WIRE)–Researched by Industrial Info Resources — Around the world, large-scale refineries are nearing completion after years in the works...
-
25.0KNew Global Refinery Capacity Caters to High-Demand Hotspots, an Industrial Info News Alert
SUGAR LAND, Texas–(BUSINESS WIRE)–Researched by Industrial Info Resources — Around the world, large-scale refineries are nearing completion after years in the works...
-
22.4KL�Officiel Inc. SAS Granted Permits by the Ministry of Home Affairs of Malaysia to Publish Locally and Achieved Another Milestone Under the Direct Owner�s Model
NEW YORK & HONG KONG & SINGAPORE–(BUSINESS WIRE)–L�Officiel Inc. SAS (�L�Officiel�), a subsidiary of AMTD IDEA Group (NYSE: AMTD; SGX: HKB), announced...
-
26.1KL�Officiel Inc. SAS Granted Permits by the Ministry of Home Affairs of Malaysia to Publish Locally and Achieved Another Milestone Under the Direct Owner�s Model
NEW YORK & HONG KONG & SINGAPORE–(BUSINESS WIRE)–L�Officiel Inc. SAS (�L�Officiel�), a subsidiary of AMTD IDEA Group (NYSE: AMTD; SGX: HKB), announced...
-
24.6KOliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration
SUWON, South Korea–(BUSINESS WIRE)–#AMD—OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient has been...
-
27.7KOliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi Therapeutic OLX10212 for Dry and Wet Age-related Macular Degeneration
SUWON, South Korea–(BUSINESS WIRE)–#AMD—OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient has been...
-
28.1KAsia�s Largest Biotech Event, BIO KOREA 2023 to Be Held From May 10 to 12 in Seoul
SEOUL, South Korea–(BUSINESS WIRE)–#BIOKOREA—BIO KOREA 2023, Korea�s top Biotech event representing Asia, will take place from May 10th to 12th at COEX...
-
25.9KArizona Sonoran Drills 547 ft (167 m) of 1.14% CuT at Parks/Salyer
CASA GRANDE, Ariz. & TORONTO–(BUSINESS WIRE)–$ASCU #Arizona—Arizona Sonoran Copper Company Inc. (TSX:ASCU | OTCQX:ASCUF) (�ASCU� or the �Company�) infill drilling at the...
-
26.5KFiscalNote Announces Major New Customer Agreements with International Governments, Embassies, Agencies, Parliaments, and Ministries Across the Global Public Sector
Governments Increasingly Rely on FiscalNote�s Geopolitical, Policy, and Political Intelligence – Powered by AI – For Legislative Tracking, Issue Monitoring, and Critical...
To Top